MedNet Solutions Recognized as one of the Fastest Growing US Companies
MedNet Solutions Recognized as one of the Fastest Growing US Companies
MINNETONKA, MN, August 27, 2007-MedNet Solutions, a health care technology company specializing in clinical study management systems, has been recognized this month by both Entrepreneur magazine and Inc. magazine as one of the nation’s most rapidly growing companies. MedNet is listed as number 157 on Entrepreneur’s “Hot 500” list of entrepreneurial businesses for 2007, and number 2059 on the “Inc. 5000” list of the United States’ fastest growing private companies.
“It’s truly an honor to be named to both of these prestigious listings,” said Rob Robertson, president and chief executive officer of MedNet Solutions. “Our quick, yet controlled and profitable growth can be attributed to three important factors-the high quality of our technology offerings, the strong business partnerships we have formed with our customers, and the tremendous dedication and hard work of our staff. As our company continues to gain momentum, it’s gratifying to see our efforts paying off and to have our success recognized within the business community. We’re especially proud to be the top-ranked ‘Hot 500’ healthcare company in Minnesota-a state renowned for being a hotbed of medical technology-related organizations.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
